Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Ann R. Falsey, Robert W. Frenck, Nicholas Kitchin
New England Journal of Medicine (2021) Vol. 385, Iss. 17, pp. 1629-1631
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
Jefferson M. Jones, Mars Stone, Hasan Sulaeman, et al.
JAMA (2021) Vol. 326, Iss. 14, pp. 1400-1400
Open Access | Times Cited: 189
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Lindsey Wang, QuanQiu Wang, Pamela B. Davis, et al.
World Psychiatry (2021) Vol. 21, Iss. 1, pp. 124-132
Open Access | Times Cited: 124
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
Rüdiger Groß, Michelle Zanoni, Alina Seidel, et al.
EBioMedicine (2021) Vol. 75, pp. 103761-103761
Open Access | Times Cited: 124
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing
Mary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 61
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants
Yuxin Chen, Lin Chen, Shengxia Yin, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1524-1536
Open Access | Times Cited: 48
COVID‐19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021
Lindsey Wang, Pamela B. Davis, David C. Kaelber, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 421-432
Open Access | Times Cited: 43
Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
Ralf Duerr, Dacia Dimartino, Christian Marier, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 18
Open Access | Times Cited: 52
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme
Clare L. Fasching, Venice Servellita, Bridget McKay, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 7
Open Access | Times Cited: 28
mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland
Matthias P. Hilty, Stefanie Keiser, Pedro David Wendel‐Garcia, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 3, pp. 362-365
Open Access | Times Cited: 23
Olfactory immunology: the missing piece in airway and CNS defence
Sebastian A. Wellford, E. Ashley Moseman
Nature reviews. Immunology (2023) Vol. 24, Iss. 6, pp. 381-398
Closed Access | Times Cited: 13
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1706-1706
Open Access | Times Cited: 10
An Overview of Post–COVID-19 Condition (Long COVID)
Thyna Vu, Sarah C. McGill
Canadian Journal of Health Technologies (2021) Vol. 1, Iss. 9
Open Access | Times Cited: 22
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171
H Zhang, Jing Zhou, Hong Chen, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 68, Iss. 1
Open Access | Times Cited: 8
A study on the side effects caused by the Pfizer/BioNTech COVID-19 vaccine: Focus on IgG antibodies and serological biomarkers
Kameran M. Ali, Ayad M. Ali, Peshnyar Muhammad Atta, et al.
Central European Journal of Immunology (2024) Vol. 49, Iss. 1, pp. 2-10
Open Access | Times Cited: 2
In Vitro Effect of Taraxacum officinale Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants
Hoai Thi Thu Tran, Michael Gigl, Nguyen Phan Khoi Le, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1055-1055
Open Access | Times Cited: 19
Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions
Michael J. Peluso, Joanna Donatelli, Timothy J. Henrich
Translational research (2021) Vol. 241, pp. 1-12
Open Access | Times Cited: 18
Breakthrough Infection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Delhi: A Single-Institution Study
Pragya Sharma, Suruchi Mishra, Saurav Basu, et al.
Cureus (2021)
Open Access | Times Cited: 16
Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities
Shelan Liu, Min Kang, Na Zhao, et al.
Medical Review (2022) Vol. 2, Iss. 2, pp. 169-196
Open Access | Times Cited: 11
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
(2023)
Open Access | Times Cited: 6
Pediococcus pentosaceus MIANGUAN Enhances the Immune Response to Vaccination in Mice
Yulu Chen, Zhi-Jie Cao, Si‐Min Lu, et al.
Probiotics and Antimicrobial Proteins (2024) Vol. 16, Iss. 4, pp. 1117-1129
Closed Access | Times Cited: 1
Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization
Rima Moghnieh, Wajdi Haddad, Nayla Jbeily, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0306457-e0306457
Open Access | Times Cited: 1
An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward
Yu Mi Wi, Si‐Ho Kim, Kyong Ran Peck
Journal of Korean Medical Science (2022) Vol. 37, Iss. 4
Open Access | Times Cited: 8
Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021
Francesca Colavita, Silvia Meschi, Cesare Ernesto Maria Gruber, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 8
Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer‐BioNTech COVID‐19 Vaccine in Medical Employees
Asher Shafrir, Johnny Amer, David Hakimian, et al.
Hepatology Communications (2022) Vol. 6, Iss. 6, pp. 1278-1288
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top